Beyond recruiting metastatic cancer cells, fibronectin has been demonstrated to act as a strong attractant for bone marrow-derived cells (BMDCs), specifically those expressing CD117, VEGFR1 and VLA-4. The gene discussed is FN1; the disease is cancer.